OPHI

CollPlant Biotechnologies (CLGN.US) surged more than 9% during regular trading to $4.50.

The stock is up 19.84% over the past ten sessions and down 67.86% year to date. It sits 70.65% above its 52-week low of US$2.637. The intraday swing reached 10.22%.

The Nasdaq Composite is down 2.89% over the past five sessions and up 10.93% year to date.

The biotechnology industry index rose 1.4% over the same period.

Subsidiary LightSolver signed a multi-year contract with the Israeli Ministry of Defense to develop and deliver laser processing units, including an initial order covering the first 12 months of photonic computing collaboration.

The company appointed Deputy CEO and CFO Eran Rotem as chief executive officer, succeeding Yehiel Tal, effective Nov. 2, 2026. The leadership change is part of a broader cost-reduction strategy that includes halting research and development in regenerative medicine.

Based on public media reports. AI-generated; not investment advice.